Programmable polymeric drugs
US11312736B1 · kind B1 · utility
21Cited by
60References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 2021 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | Aug 26, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G79/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds useful as biologically active compounds are disclosed. The compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R1, R2, R3, L, L1, L2, L3, M and n are as defined herein. Methods associated with preparation and use of such compounds is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.